West Chester Capital Advisors, Inc Amarin Corp Plcuk Transaction History

West Chester Capital Advisors, Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 03, 2021	SELL	$4.04 - $5.31 $245,668 - $322,895	-60,809 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$13.89 - $23.16 $2,805 - $4,678	202 Added 0.33%	60,809 $922,000
Q2 2019 Jul 30, 2019	BUY	$16.27 - $20.51 $13,260 - $16,715	815 Added 1.36%	60,607 $1.18 Million
Q1 2019 Apr 24, 2019	BUY	$12.61 - $22.33 $753,977 - $1.34 Million	59,792 New	59,792 $1.24 Million
Q3 2018 Oct 29, 2018	SELL	$2.45 - $16.27 $25,320 - $168,150	-10,335 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$3.06 - $4.09 $31,625 - $42,270	10,335	10,335 $34,000

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $185M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of West Chester Capital Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on West Chester Capital Advisors, Inc with notifications on news.